DSM-Firmenich: reports strong improvement in Q3-2024

Kaiseraugst (CH) | Maastricht (NL). (dsf) DSM-Firmenich AG reports its financial results for the third quarter 2024. CEO Dimitri de Vreeze: «Our business maintained positive momentum through the third quarter, supported by our own improvement programs and strong performances in Perfumery and Beauty and Taste, Texture and Health. Health, Nutrition and Care saw a further gradual improvement in organic sales growth, while Animal Nutrition and Health saw good momentum in its business.»

«Our comprehensive program of sales and cost synergies, together with the vitamin transformation program continue to deliver according to our expectations, driving good financial performance and underpinning our innovation-driven growth strategy. At the same time, our strategic actions, including the carve-out of Animal Nutrition and Health and divestments of de-prioritized activities, are progressing well. Recently, we marked a key milestone in sustainability with our ambitious net-zero emissions targets receiving validation from the Science Based Targets initiative.»

Outlook

During the quarter, the vitamin market experienced a supply disruption event. The resulting increase in some vitamin prices will lead to a significant temporary profit contribution of around EUR 80 million in the fourth quarter. Consequently, the company increases its FY 2024 outlook and now expects Adjusted EBITDA towards EUR 2.1 billion. For additional information please read the Company’s PDF file below (464 KB):

20241116-DSMFIRMENICH-Q32024.